Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan K Hennigs

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Biomed Research International|April 11, 2014
The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseasesNicole Lüneburg, Lars Harbaum, Jan K Hennigs
Human Gene Therapy|October 7, 2020
Inactivation of Adeno-Associated Viral Vectors by Oxidant-Based DisinfectantsJoelle Korte, Julia Mienert, Jan K Hennigs, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 16, 2022
[Organ-specific sequelae of COVID-19 in adults]Jan K Hennigs, Tim Oqueka, Lars Harbaum, et al.
Cells|October 23, 2021
Vascular Endothelial Cells: Heterogeneity and Targeting ApproachesJan K Hennigs, Christiane Matuszcak, Martin Trepel, et al.
Respiratory Research|July 8, 2021
Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation studyLars Harbaum, Jan K Hennigs, Marcel Simon, et al.
Chest|October 7, 2015
Does circulating IL-17 identify a subset of patients with idiopathic pulmonary arterial hypertension?Lars Harbaum, Tim Oqueka, Antonia Glatzel, et al.
The European Respiratory Journal|May 3, 2014
Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapyLars Harbaum, Jan K Hennigs, Hans J Baumann, et al.
Journal of Neurochemistry|July 17, 2008
Sweet taste receptor interacting protein CIB1 is a general inhibitor of InsP3-dependent Ca2+ release in vivoJan K Hennigs, Nicole Burhenne, Frauke Stähler, et al.
ERJ Open Research|June 1, 2023
Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertensionJonna Ostermann, Julian Pott, Jan K Hennigs, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potentialJakob Körbelin, Julius Klein, Christiane Matuszcak, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Biomed Research International|April 11, 2014
The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseasesNicole Lüneburg, Lars Harbaum, Jan K Hennigs
Human Gene Therapy|October 7, 2020
Inactivation of Adeno-Associated Viral Vectors by Oxidant-Based DisinfectantsJoelle Korte, Julia Mienert, Jan K Hennigs, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 16, 2022
[Organ-specific sequelae of COVID-19 in adults]Jan K Hennigs, Tim Oqueka, Lars Harbaum, et al.
Cells|October 23, 2021
Vascular Endothelial Cells: Heterogeneity and Targeting ApproachesJan K Hennigs, Christiane Matuszcak, Martin Trepel, et al.
Respiratory Research|July 8, 2021
Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation studyLars Harbaum, Jan K Hennigs, Marcel Simon, et al.
Chest|October 7, 2015
Does circulating IL-17 identify a subset of patients with idiopathic pulmonary arterial hypertension?Lars Harbaum, Tim Oqueka, Antonia Glatzel, et al.
The European Respiratory Journal|May 3, 2014
Complete resolution of idiopathic pulmonary arterial hypertension following chemotherapyLars Harbaum, Jan K Hennigs, Hans J Baumann, et al.
Journal of Neurochemistry|July 17, 2008
Sweet taste receptor interacting protein CIB1 is a general inhibitor of InsP3-dependent Ca2+ release in vivoJan K Hennigs, Nicole Burhenne, Frauke Stähler, et al.
ERJ Open Research|June 1, 2023
Residual risk identified in routine noninvasive follow-up assessments in pulmonary arterial hypertensionJonna Ostermann, Julian Pott, Jan K Hennigs, et al.
Frontiers in Cardiovascular Medicine|January 23, 2023
Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potentialJakob Körbelin, Julius Klein, Christiane Matuszcak, et al.
Pageof 5